Kevin McKernan: Genomics, PCR, COVID Testing, mRNA Vaccines, Blockchain Technology, Psilocybin Mushroom & Cannabis Genomes | #58

Mind & Matter

English - February 15, 2022 21:00 - 1 hour - 70.6 MB - ★★★★★ - 15 ratings
Science Society & Culture science drugs psychedelics technology biotechnology innovation biology brain neuroscience startups Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Alexandra Elbakyan: Sci-Hub, Open Data, Freedom of Information & the Democratization of Science | #57

Next Episode: CBD (Cannabidiol), Antiviral Drugs, SARS-CoV-2 & Cancer Biology | Marsha Rosner | #59

Kevin McKernan is a renowned leader in DNA sequencing technology. He led a research team part of the original Human Genome Project and is the founder and Chief Science Officer of Medicinal Genomics, a life sciences company that distributes genetics-based platforms for quality and safety testing of legal cannabis.

Nick and Kevin discussed the Cannabis genome, the genome of Psilocybe cubensis (magic mushrooms); Polymerase Chain Reaction (PCR) technology, how it works, and how it's used for COVID-19 testing; cannabinoids such as cannabidiol (CBD) and recent research indicating their potential anti-SARS-CoV-2 effects; blockchain technology for genomics data; and mRNA vaccines and SARS-CoV-2.

Support M&M:
Sign up for the weekly Mind & Matter newsletter
[https://mindandmatter.substack.com/?sort=top]

The Amino Co., shop science-back amino acids supplements. Use code ‘MIND’ to save 30%.
[aminoco.com/MIND]

Follow Nick's work through Linktree:
[https://linktr.ee/trikomes]

Organize your digital highlights & notes w/ Readwise (2 months free w/ sub)[https://readwise.io/nickjikomes/]

Learn more about our podcast sponsor, Dosist
[https://dosist.com]

Support the show